Lactoferrin modulation of BCG-infected dendritic cell functions

International Immunology

Volumn 21, Issue 10, 2009, Pages 1185-1197

  Hwang, Shen An ^a   Actor, Jeffrey K ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Adjuvant; BCG; Dendritic cells; Lactoferrin; Tuberculosis

Indexed keywords

B7 ANTIGEN; BCG VACCINE; CD40 ANTIGEN; CD86 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 12P40; INTERLEUKIN 6; L SELECTIN; LACTOFERRIN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MONOCYTE CHEMOTACTIC PROTEIN 1; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; ANTIGENIC MODULATION; ARTICLE; BONE MARROW CELL; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL FUNCTION; CELL SURFACE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DRUG POTENTIATION; DRUG SCREENING; FEMALE; IMMUNOMODULATION; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE ACTIVATION; UPREGULATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGENS, CD40; ANTIGENS, CD80; ANTIGENS, CD86; BCG VACCINE; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS II; LACTOFERRIN; MICE; MICE, INBRED C57BL; MYCOBACTERIUM BOVIS; TUBERCULOSIS;

EID: 70349558633     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxp084     Document Type: Article

References (62)

1. Tuberculosis Fact Sheet No. 104. In. World Heath Organization. WHO Press, Geneva.
2. Global Tuberculosis Control: Surveillance, Planning, Financing: WHO Report 2008. World Health Organization, Geneva. WHO/HTM/TB/2008.393.
3. Andersen, P. and Doherty, T. M. 2005. The success and failure of BCG - implications for a novel tuberculosis vaccine. Nat. Rev. Microbiol. 3:656.
4. Sterne, J. A., Rodrigues, L. C. and Guedes, I. N. 1998. Does the efficacy of BCG decline with time since vaccination? Int. J. Tuberc. Lung Dis. 2:200.
5. Doherty, T. M. 2005. Real world TB vaccines: Clinical trials in TB-endemic regions. Vaccine 23:2109.
6. Gupta, U. D., Katoch, V. M. and McMurray, D. N. 2007. Current status of TB vaccines. Vaccine 25:3742.
7. Ly, L. H. and McMurray, D. N. 2008. Tuberculosis: Vaccines in the pipeline. Expert Rev. Vaccines 7:635.
8. Aldwell, F. E., Baird, M. A., Fitzpatrick, C. E. et al. 2005. Oral vaccination of mice with lipid-encapsulated Mycobacterium bovis BCG: Anatomical sites of bacterial replication and immune activity. Immunol. Cell Biol. 83:549.
9. Aldwell, F. E., Brandt, L., Fitzpatrick, C. and Orme, I. M. 2005. Mice fed lipid-encapsulated Mycobacterium bovis BCG are protected against aerosol challenge with Mycobacterium tuberculosis. Infect. Immun. 73:1903.
10. Haile, M., Schroder, U., Hamasur, B. et al. 2004. Immunization with heat-killed Mycobacterium bovis bacille Calmette-Guerin (BCG) in Eurocine L3 adjuvant protects against tuberculosis. Vaccine 22:1498.
11. Chambers, M. A., Wright, D. C., Brisker, J. et al. 2004. A single dose of killed Mycobacterium bovis BCG in a novel class of adjuvant (Novasome) protects guinea pigs from lethal tuberculosis. Vaccine 22:1063.
12. Kirby, D. J., Rosenkrands, I., Agger, E. M., Andersen, P., Coombes, A. G. and Perrie, Y. 2008. PLGA microspheres for the delivery of a novel subunit TB vaccine. J. Drug Target 16:282.
13. Clark, S., Cross, M. L., Nadian, A. et al. 2008. Oral vaccination of guinea pigs with a Mycobacterium bovis bacillus Calmette-Guerin vaccine in a lipid matrix protects against aerosol infection with virulent M. bovis. Infect. Immun. 76:3771.
14. Levay, P. F. and Viljoen, M. 1995. Lactoferrin: A general review. Haematologica 80:252.
15. Brock, J. H. 2002. The physiology of lactoferrin. Biochem. Cell Biol. 80:1.
16. Sorimachi, K., Akimoto, K., Hattori, Y., Ieiri, T. and Niwa, A. 1997. Activation of macrophages by lactoferrin: Secretion of TNF-alpha, IL-8 and NO. Biochem. Mol. Biol. Int. 43:79.
17. Na, Y. J., Han, S. B., Kang, J. S. et al. 2004. Lactoferrin works as a new LPS-binding protein in inflammatory activation of macrophages. Int. Immunopharmacol. 4:1187.
18. Actor, J. K., Hwang, S. A., Olsen, M., Zimecki, M., Hunter, R. L. Jr and Kruzel, M. L. 2002. Lactoferrin immunomodulation of DTH response in mice. Int. Immunopharmacol. 2:475.
19. Dhennin-Duthille, I., Masson, M., Damiens, E., Fillebeen, C., Spik, G. and Mazurier, J. 2000. Lactoferrin upregulates the expression of CD4 antigen through the stimulation of the mitogen-activated protein kinase in the human lymphoblastic T Jurkat cell line. J. Cell Biochem. 79:583.
20. Zimecki, M., Mazurier, J., Spik, G. and Kapp, J. A. 1995. Human lactoferrin induces phenotypic and functional changes in murine splenic B cells. Immunology 86:122.
21. Zimecki, M., Kocieba, M. and Kruzel, M. 2002. Immunoregulatory activities of lactoferrin in the delayed type hypersensitivity in mice are mediated by a receptor with affinity to mannose. Immunobiology 205:120.
22. Zimecki, M. and Kruzel, M. L. 2000. Systemic or local co-administration of lactoferrin with sensitizing dose of antigen enhances delayed type hypersensitivity in mice. Immunol. Lett. 74:183.
23. Hwang, S. A., Kruzel, M. L. and Actor, J. K. 2005. Lactoferrin augments BCG vaccine efficacy to generate T helper response and subsequent protection against challenge with virulent Mycobacterium tuberculosis. Int. Immunopharmacol. 5:591.
24. Hwang, S. A., Wilk, K. M., Budnicka, M. et al. 2007. Lactoferrin enhanced efficacy of the BCG vaccine to generate host protective responses against challenge with virulent Mycobacterium tuberculosis. Vaccine 25:6730.
25. Hwang, S. A., Wilk, K. M., Bangale, Y. A., Kruzel, M. L. and Actor, J. K. 2007. Lactoferrin modulation of IL-12 and IL-10 response from activated murine leukocytes. Med. Microbiol. Immunol. 196:171.
26. Constant, S. L. and Bottomly, K. 1997. Induction of Th1 and Th2 CD4+ T cell responses: The alternative approaches. Annu. Rev. Immunol. 15:297.
27. Schmitt, E., Hoehn, P., Huels, C. et al. 1994. T helper type 1 development of naive CD4+ T cells requires the coordinate action of interleukin-12 and interferon-gamma and is inhibited by transforming growth factor-beta. Eur. J. Immunol. 24:793.
28. Seder, R. A., Gazzinelli, R., Sher, A. and Paul, W. E. 1993. Interleukin 12 acts directly on CD4+ T cells to enhance priming for interferon gamma production and diminishes interleukin 4 inhibition of such priming. Proc. Natl Acad. Sci. USA 90:10188.
29. Wilk, K. M., Hwang, S. A. and Actor, J. K. 2007. Lactoferrin modulation of antigen-presenting-cell response to BCG infection. Postepy Hig. Med. Dosw. (Online). 61:277.
30. Hwang, S. A., Kruzel, M. L. and Actor, J. K. 2009. Influence of bovine lactoferrin on expression of presentation molecules on BCGinfected bone marrow derived macrophages. Biochimie. 91:76.
31. Guermonprez, P., Valladeau, J., Zitvogel, L., Thery, C. and Amigorena, S. 2002. Antigen presentation and T cell stimulation by dendritic cells. Annu. Rev. Immunol. 20:621.
32. Cumberbatch, M., Dearman, R. J., Uribe-Luna, S. et al. 2000. Regulation of epidermal Langerhans cell migration by lactoferrin. Immunology 100:21.
33. Griffiths, C. E., Cumberbatch, M., Tucker, S. C. et al. 2001. Exogenous topical lactoferrin inhibits allergen-induced Langerhans cell migration and cutaneous inflammation in humans. Br. J. Dermatol. 144:715.
34. Kimber, I., Cumberbatch, M., Dearman, R. J., Headon, D. R., Bhushan, M. and Griffiths, C. E. 2002. Lactoferrin: Influences on Langerhans cells, epidermal cytokines, and cutaneous inflammation. Biochem. Cell Biol. 80:103.
35. Cumberbatch, M., Bhushan, M., Dearman, R. J., Kimber, I. and Griffiths, C. E. 2003. IL-1beta-induced Langerhans' cell migration and TNF-alpha production in human skin: Regulation by lactoferrin. Clin. Exp. Immunol. 132:352.
36. de la Rosa, G., Yang, D., Tewary, P., Varadhachary, A. and Oppenheim, J. J. 2008. Lactoferrin acts as an alarmin to promote the recruitment and activation of APCs and antigen-specific immune responses. J. Immunol. 180:6868.
37. Mikkelsen, T. L., Bakman, S., Sorensen, E. S., Barkholt, V. and Frokiaer, H. 2005. Sialic acid-containing milk proteins show differential immunomodulatory activities independent of sialic acid. J. Agric. Food Chem. 53:7673.
38. Spadaro, M., Caorsi, C., Ceruti, P. et al. 2008. Lactoferrin, a major defense protein of innate immunity, is a novel maturation factor for human dendritic cells. Faseb J. 22:2747.
39. Fulton, S. A., Reba, S. M., Pai, R. K. et al. 2004. Inhibition of major histocompatibility complex II expression and antigen processing in murine alveolar macrophages by Mycobacterium bovis BCG and the 19-kilodalton mycobacterial lipoprotein. Infect. Immun. 72:2101.
40. Sendide, K., Deghmane, A. E., Pechkovsky, D., Av-Gay, Y., Talal, A. and Hmama, Z. 2005. Mycobacterium bovis BCG attenuates surface expression of mature class II molecules through IL-10-dependent inhibition of cathepsin S. J. Immunol. 175:5324.
41. Wojciechowski, W., DeSanctis, J., Skamene, E. and Radzioch, D. 1999. Attenuation of MHC class II expression in macrophages infected with Mycobacterium bovis bacillus Calmette-Guerin involves class II transactivator and depends on the Nramp1 gene. J. Immunol. 163:2688.
42. Kruzel, M. L., Actor, J. K., Boldogh, I. and Zimecki, M. 2007. Lactoferrin in health and disease. Postepy Hig. Med. Dosw. (Online). 61:261.
43. Hwang, S. A., Kruzel, M. L. and Actor, J. K. 2009. Influence of bovine lactoferrin on expression of presentation molecules on BCGinfected bone marrow derived macrophages. Biochimie. 91:76.
44. Moulton, R. A., Mashruwala, M. A., Smith, A. K. et al. 2007. Complement C5a anaphylatoxin is an innate determinant of dendritic cell-induced Th1 immunity to Mycobacterium bovis BCG infection in mice. J. Leukoc. Biol. 82:956.
45. Guidry, T. V., Hunter, R. L. Jr. and Actor, J. K. 2006. CD3+ cells transfer the hypersensitive granulomatous response to mycobacterial glycolipid trehalose 6,6′-dimycolate in mice. Microbiology 152:3765.
46. O'Sullivan, B. and Thomas, R. 2003. CD40 and dendritic cell function. Crit. Rev. Immunol. 23:83.
47. Schaible, U. E., Collins, H. L., Priem, F. and Kaufmann, S. H. 2002. Correction of the iron overload defect in beta-2-microglobulin knockout mice by lactoferrin abolishes their increased susceptibility to tuberculosis. J. Exp. Med. 196:1507.
48. Schuurhuis, D. H., Fu, N., Ossendorp, F. and Melief, C. J. 2006. Ins and outs of dendritic cells. Int. Arch. Allergy Immunol. 140:53.
49. Greenwald, R. J., Freeman, G. J. and Sharpe, A. H. 2005. The B7 family revisited. Annu. Rev. Immunol. 23:515.
50. McAdam, A. J., Schweitzer, A. N. and Sharpe, A. H. 1998. The role of B7 co-stimulation in activation and differentiation of CD4+ and CD8+ T cells. Immunol. Rev. 165:231.
51. Bhatia, S., Edidin, M., Almo, S. C. and Nathenson, S. G. 2006. B7-1 and B7-2: Similar costimulatory ligands with different biochemical, oligomeric and signaling properties. Immunol. Lett. 104:70.
52. Collins, M., Ling, V. and Carreno, B. M. 2005. The B7 family of immune-regulatory ligands. Genome Biol. 6:223.
53. Pentcheva-Hoang, T., Egen, J. G., Wojnoonski, K. and Allison, J. P. 2004. B7-1 and B7-2 selectively recruit CTLA-4 and CD28 to the immunological synapse. Immunity 21:401.
54. Lang, T. J., Nguyen, P., Peach, R., Gause, W. C. and Via, C. S. 2002. In vivo CD86 blockade inhibits CD4+ T cell activation, whereas CD80 blockade potentiates CD8+ T cell activation and CTL effector function. J. Immunol. 168:3786.
55. Sallusto, F., Geginat, J. and Lanzavecchia, A. 2004. Central memory and effector memory T cell subsets: Function, generation, and maintenance. Annu. Rev. Immunol. 22:745.
56. Langenkamp, A., Messi, M., Lanzavecchia, A. and Sallusto, F. 2000. Kinetics of dendritic cell activation: Impact on priming of TH1, TH2 and nonpolarized T cells. Nat. Immunol. 1:311.
57. Taub, D. D., Proost, P., Murphy, W. J. et al. 1995. Monocyte chemotactic protein-1 (MCP-1), -2, and -3 are chemotactic for human T lymphocytes. J. Clin. Invest. 95:1370.
58. Foti, M., Granucci, F., Aggujaro, D. et al. 1999. Upon dendritic cell (DC) activation chemokines and chemokine receptor expression are rapidly regulated for recruitment and maintenance of DC at the inflammatory site. Int. Immunol. 11:979.
59. Li, M. O., Wan, Y. Y., Sanjabi, S., Robertson, A. K. and Flavell, R. A. 2006. Transforming growth factor-beta regulation of immune responses. Annu. Rev. Immunol. 24:99.
60. Hmama, Z., Gabathuler, R., Jefferies, W. A., de Jong, G. and Reiner, N. E. 1998. Attenuation of HLA-DR expression by mononuclear phagocytes infected with Mycobacterium tuberculosis is related to intracellular sequestration of immature class II heterodimers. J. Immunol. 161:4882.
61. Pennini, M. E., Pai, R. K., Schultz, D. C., Boom, W. H. and Harding, C. V. 2006. Mycobacterium tuberculosis 19-kDa lipoprotein inhibits IFN-gamma-induced chromatin remodeling of MHC2TA by TLR2 and MAPK signaling. J. Immunol. 176:4323.
62. Majlessi, L., Combaluzier, B., Albrecht, I. et al. 2007. Inhibition of phagosome maturation by mycobacteria does not interfere with presentation of mycobacterial antigens by MHC molecules. J. Immunol. 179:1825.